Allele Biotechnology and Pharmaceuticals, Inc.
PrivateLast Round
Grant
Jan 14, 2026
Total Funding Raised
$7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Allele Biotechnology and Pharmaceuticals, Inc. is a biotechnology company that develops mRNA-based reprogramming technologies, cGMP-grade induced pluripotent stem cell (iPSC) lines, and specialized CDMO services for regenerative medicine and drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Government Contracts, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Allele Biotechnology and Pharmaceuticals, Inc. Comparables
Compare Allele Biotechnology and Pharmaceuticals, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| iXCells Biotechnologies | 84% | |
| Applied StemCell, Inc. | 79% | |
| NanoTag Biotechnologies | 77% |
Allele Biotechnology and Pharmaceuticals, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 14, 2026 | ||||
| Grant | Oct 15, 2018 | ||||
| Series A | Sep 25, 2014 |
Allele Biotechnology and Pharmaceuticals, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ARPA-H | Grant |
| National Institute of General Medical Sciences | Grant |
| Yifang Technology Group | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 23, 2026
Grew 16% QoQ, from 25 to 29 employees.
- Jan 14, 2026
Received funding from ARPA-H.
Allele Biotechnology and Pharmaceuticals, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Allele Biotechnology and Pharmaceuticals, Inc.'s valuation, stock price, and market status.
Is Allele Biotechnology and Pharmaceuticals, Inc. a public or private company?
Allele Biotechnology and Pharmaceuticals, Inc. is a private company.
What is the current stock price of Allele Biotechnology and Pharmaceuticals, Inc.?
Allele Biotechnology and Pharmaceuticals, Inc. is a private company with no public stock price. Caplight tracks Allele Biotechnology and Pharmaceuticals, Inc.'s secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Allele Biotechnology and Pharmaceuticals, Inc. worth (valuation)?
Valuation information for Allele Biotechnology and Pharmaceuticals, Inc. is not publicly available.
Can I buy Allele Biotechnology and Pharmaceuticals, Inc. stock?
Allele Biotechnology and Pharmaceuticals, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Allele Biotechnology and Pharmaceuticals, Inc.'s last funding round?
Allele Biotechnology and Pharmaceuticals, Inc.'s most recent funding round was Grant on January 14, 2026.
Who are the main investors in Allele Biotechnology and Pharmaceuticals, Inc.?
Key investors in Allele Biotechnology and Pharmaceuticals, Inc. include ARPA-H, National Institute of General Medical Sciences, Yifang Technology Group.
Will Allele Biotechnology and Pharmaceuticals, Inc. IPO soon?
No public IPO plans have been announced for Allele Biotechnology and Pharmaceuticals, Inc..
How can I track Allele Biotechnology and Pharmaceuticals, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Allele Biotechnology and Pharmaceuticals, Inc.'s secondary market activity and sign up for updates.